Phase 3 Myasthenia Gravis Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• (USA only) You must be between 12 and 17 years old at the time of signing the consent form
• (Outside USA) You must be between 6 and 17 years old at the time of signing the consent form
• (USA only) You must have received a meningococcal vaccine covering strains A, B, C, W, and Y within the last 3 years, and at least 2 weeks before starting the study
• (Outside USA) You must have received a meningococcal vaccine covering strains A, C, W, and Y (and B if available in your country) within the last 3 years before starting the study — if the vaccine was given less than 2 weeks before starting, you would need to take preventive antibiotics for at least 2 weeks
• You must have been diagnosed with Myasthenia Gravis (MG) — a condition causing muscle weakness — that falls into a moderate or more severe category as defined by a recognised medical classification system (confirm with trial site)
• You must have a positive blood test showing specific antibodies linked to MG (called AChR antibodies)

Who may not be able to join:

• People who have had their thymus gland removed or had any other thymus surgery within the past 12 months
• People who have an untreated cancerous or abnormal growth on the thymus gland
• People who have previously had a serious bacterial infection called meningococcal disease
• People who are pregnant, breastfeeding, or planning to become pregnant during the study

Important: Always verify eligibility with the trial site directly before applying.